✦ LIBER ✦

(456) Effectiveness and safety of oxycodone/naloxone controlled release tablets during three 52-week open-label extension studies

✍ Scribed by Moline, M.; Berger, B.; Dain, B.; Munera, C.; Hopp, M.; Green, J.

Book ID: 122121685
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 93 KB
Volume: 15
Category: Article
ISSN: 1528-8447
DOI: 10.1016/j.jpain.2014.01.367

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

334 – Long-term safety/tolerability of p

334 – Long-term safety/tolerability of paliperidone extended-release tablets: 52-week, open-label extension study

✍ M. Kramer; G. Simpson; S. Kushner; Y. Liu; P. Lim; D. Hough; M. Eerdekens; J. Pa 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Poster 528 Open-Label Extension of a Ran

Poster 528 Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Safety and Analgesic Efficacy of MNK-795 Oxycodone/Acetaminophen Extended-Release Tablets in an Acute Pain Model

✍ Singla, Neil; Barrett, Thomas; Sisk, Lisa; Kostenbader, Kenneth; Young, Jim 📂 Article 📅 2014 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 65 KB

Safety and Tolerability of Oral Paliperi

Safety and Tolerability of Oral Paliperidone Extended-Release Tablets in Elderly Patients With Schizophrenia: A Double-Blind, Placebo-Controlled Study With Six-Month Open-Label Extension

✍ Tzimos, Andreas; Samokhvalov, Viktor; Kramer, Michelle; Ford, Lisa; Gassmann-May 📂 Article 📅 2008 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 150 KB